Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
CG Oncology Q3 Loss Widens, Revenue Declines

CG Oncology Q3 Loss Widens, Revenue Declines

MT newswireMT newswire2026/11/06 12:42
08:42 AM EST, 11/06/2026 (MT Newswires) -- CG Oncology (CGON) reported Friday a Q3 loss of $0.64 per share, compared with a loss of $0.57 a year earlier. Analysts polled by FactSet expected a loss of $0.84. Revenue for the quarter ended Sept. 30 was $1.6 million, down from $1.7 million a year earlier. Analysts expected $500,000.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!